Study Objectives: To determine whether chronic oral estrogen replacement th
erapy (ERT) (1) improves the sleep of older, non-symptomatic postmenopausal
women; and (2) reduces the sleep disruption associated with a stressor (fr
equent remote nocturnal blood-sampling through an intravenous catheter).
Design: Descriptive, cross-sectional, secondary analysis of a larger study.
Setting: The General Clinical Research Center at the University of Washingt
on Medical Center.
Participants: Women aged 57-80 (mean age = 70) at least 5 years past menopa
use were recruited from the community. Hot flashes and significant sleep di
fficulties were exclusion criteria. The ERT group (n=37) consisted of women
on chronic oral ERT for greater than or equal to2 years. The NERT group (n
=56) consisted of women not using estrogen (NERT) for greater than or equal
to2 years.
Interventions: N/A
Measurements and Results: Following an adaptation night, polysomnographic m
easures were collected for 2 consecutive nights. A blood sample was collect
ed every 20 minutes for the last 24 hours (including Night 2), through an i
ntravenous catheter. The only group difference in sleep on the baseline (no
n-catheter) night was that NERT women had a shorter sleep latency. Sleep on
the catheter night was characterized by increased wakefulness, longer slee
p latency, and decreased REM sleep for both groups relative to the baseline
. However, the impact of nocturnal blood sampling was much greater for INER
T than for ERT women: they experienced significantly greater percent change
s in more sleep-wake variables, particularly slow-wave sleep (SWS).
Conclusions: In this cross-sectional study, the use of chronic oral ERT was
associated with little effect on the sleep of older postmenopausal women n
ot experiencing hot flashes, except in the presence of a challenge to sleep
. ERT ameliorated the disruptive effect of nocturnal blood sampling on both
objectively assessed and subjectively assessed sleep.